Literature DB >> 10829146

Rehabilitation for elderly patients with cancer asthenia: making a transition to palliative care.

S Scialla1, R Cole, T Scialla, L Bednarz, J Scheerer.   

Abstract

The transition from curative to palliative care for elderly patients with cancer-related asthenia presents complex challenges to oncologists. A result of this complexity is a lack of regard for the maintenance of physical and mental function. This study examined the effects of comprehensive, multidisciplinary, inpatient rehabilitation on the physical and mental function of elderly cancer patients with asthenia. We found that both physical and mental function improved following inpatient rehabilitation. However, it is difficult to predict which patients benefit most from rehabilitation. Nevertheless, functional improvement following rehabilitation may allow medical caregivers to better distribute the type and intensity of care, and reduce the caregiver burden experienced by family members in the home.

Entities:  

Mesh:

Year:  2000        PMID: 10829146     DOI: 10.1191/026921600666299204

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  3 in total

1.  Utilization of rehabilitation services for inpatient with cancer in Taiwan: a descriptive analysis from national health insurance database.

Authors:  Heui-Fen Lin; Ying-Tai Wu; Jau-Yih Tsauo
Journal:  BMC Health Serv Res       Date:  2012-08-16       Impact factor: 2.655

2.  Assessment of the effects of a multi-component, individualized physiotherapy program in patients receiving hospice services in the home.

Authors:  Agnieszka Ćwirlej-Sozańska; Agnieszka Wójcicka; Edyta Kluska; Anna Stachoń; Anna Żmuda
Journal:  BMC Palliat Care       Date:  2020-07-09       Impact factor: 3.234

3.  Opinion versus practice regarding the use of rehabilitation services in home care: an investigation using machine learning algorithms.

Authors:  Lu Cheng; Mu Zhu; Jeffrey W Poss; John P Hirdes; Christine Glenny; Paul Stolee
Journal:  BMC Med Inform Decis Mak       Date:  2015-10-09       Impact factor: 2.796

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.